MEDICINOVA, INC. (MNOV) Operating income 2016–2025
MEDICINOVA, INC. (MNOV) annual operating income history from SEC filings — each fiscal year as reported.
-$13.3MFY2025 · since FY2016: -$10.9M → -$13.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$13.3M | -4.8% |
| FY2024 | -$12.7M | -28.0% |
| FY2023 | -$9.9M | +32.3% |
| FY2022 | -$14.6M | -43.2% |
| FY2021 | -$10.2M | +27.9% |
| FY2020 | -$14.2M | -1.0% |
| FY2019 | -$14.0M | +10.0% |
| FY2018 | -$15.6M | -19.6% |
| FY2017 | -$13.0M | -19.7% |
| FY2016 | -$10.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More MNOV financial trends
MNOV RevenueMNOV Net incomeMNOV Net marginMNOV Gross profitMNOV Gross marginMNOV Operating marginMNOV Operating cash flowMNOV Free cash flowMNOV Capital expendituresMNOV Return on equityMNOV Stock buybacksMNOV Dividends paidMNOV Total assetsMNOV Total liabilitiesMNOV Shareholders’ equityMNOV overview →